BETTER THERAPEUTICS Stock Price, News & Analysis

MCADR NASDAQ

Company Description

BETTER THERAPEUTICS (NASDAQ: MCADR) is a publicly traded company.

MCADR stock has gained 232.3% over the past year.

This page provides a comprehensive overview of MCADR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+232.26%

Performance 1 year

$0.0

Market Cap

7.6M

Shares outstanding

BETTER THERAPEUTICS (MCADR) stock. Over the past 12 months, the stock has gained 232.3%.

Latest News

View All

March 15, 2021

—

Mountain Crest Acquisition Corp. II Announces that Common Stock and Rights to Commence Separate Trading on or about March 17, 2021

acquisition

January 15, 2021

—

Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering

IPO offering acquisition

January 13, 2021

—

Mountain Crest Acquisition Corp. II Announces Closing of $50 Million Initial Public Offering

IPO offering acquisition

January 8, 2021

—

Mountain Crest Acquisition Corp. II Announces Pricing of $50 Million Initial Public Offering

IPO offering acquisition

BETTER THERAPEUTICS has 4 recent news articles. Key topics include acquisition, IPO, offering. View all MCADR news →

SEC Filings

View All

No SEC filings available for MCADR.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months